ENA0000GenomicsThe Ohio State Universityhttps://www.ebi.ac.uk/ena/browser/view/PRJNA241076Homo sapiensWe generated H460 cells with acquired TRAIL resistance by exposing the parental sentisitve cells to subtoxic concentrations of TRAIL for 6 months. Then we compared the microRNA expression profile in the sensitive versus resistant cells. Overall design: H460 cells were treated with subtoxic concentrations of TRAIL for 6 month. After confirmation of the resistance, the RNA was extracted and the microRNA expression profile was analyzed using the NanoString technology.ENACD253, protein TRAIL, dTAF[[II]]230, TAF[[II]]250, d230, H460, insensitive, apo-2 ligand, stRNA, Apo-2L, TAF200, l(3)84Ab, micro RNA, dTAFII250, BG:DS00004.13, TNFSF10, TAFII-250, TAF250/230, EfW1, Cell, dTAF230, dmTAF[[II]]230, TRAIL, TAFII250, dmTAF1, sensitive, Taf230, p230, TAF[[II]]250/230, TFIID, TL2, sensitivity, TAF250, NCI-460, Taf[[II]]250, small temporal RNA, hypersensitivity, apo-2L, Taf200, hypersensitive, dTAF[[II]]250, TAF[[II]]230, resistant, TFIID TAF250, cel, cell, Taf1p, TAF[II]250, TNF-related apoptosis-inducing ligand, CG17603, TAF[[II]], INSDC_feature:ncRNA, INSDC_qualifier:miRNA, allergic reaction, H-460, dTAF250, APO2L, DmelCG17603, TAF1., Taf250, SR3-5, hypersensitivity reaction disease, NCI-HUT-460, hypersensitivity reaction, TAF, microRNA, TAF230human being, human., man0.00.00.00.00.00falseHomo sapiensMicroRNA expression profile in TRAIL-sensitive and -resistant H460 cells2022-05-122014-09-01PRJNA241076GSE55821260804259606